Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesBilobectomy for non-small cell lung cancer: A search for clinical factors that may affect perioperative morbidity and long-term survival
The Journal of Thoracic and Cardiovascular Surgery, 08/28/09
Kim AW et al. – Bilobectomy can be performed with acceptable morbidity and mortality. Survival relates to disease stage. Optimal survival benefit occurs when the indication for bilobectomy is squamous cell carcinoma extending across the fissure.
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
A small-cell lung cancer genome with complex signatures of tobacco exposure
Nature, 12/18/09
Today in Surgery/Trauma...keeping you current
Receive free subspecialty "5-minute updates" via email
Poor Late Survival After Surgical Treatment of Pleural Empyema
World Journal of Surgery, 12/18/09
Prospective population-based study comparing quality of life after pneumonectomy and lobectomy
European Journal of Cardio-Thoracic Surgery, 12/18/09
Pneumonectomy due to lung cancer results in a more pronounced activation of coagulation system than lobectomy
European Journal of Cardio-Thoracic Surgery, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor